Study to Evaluate the Bioequivalence of Astellas Phama Korea Inc. "Harnal-D" in Healthy Volunteers After Meal

Clinical trial NCT03887871 · COMPLETED

Trial details

NCT number: NCT03887871
Sponsor: Chong Kun Dang Pharmaceutical
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Benign Prostatic Hyperplasia

Start date: 2019-03-11
Primary completion: 2019-03-22
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.